Epinephrine as good as epinephrine and vasopressin combo in pediatric CPR: study
Return of spontaneous circulation (ROSC) is the initial therapeutic goal in cardiac arrest and is a measure of initial success of CPR. Cardiopulmonary resuscitation involves chest compressions, manual ventilation and vasopressor drugs at appropriate intervals. Pediatric advanced life support(PALS) guidelines recommend epinephrine as the first line vasopressor in pediatric cardiac arrest but the recent advanced cardio-vascular life support guideline recommends that Vaso-pressin, combined with epinephrine, may be considered in adult cardiac arrest resuscitation.
Team of Pediatricians from JIPMER,Puducherry conducted a study to compare the efficacy of epinephrine plus vasopressin vs epinephrine plus placebo in the pediatric intensive care unit (PICU) cardiopulmonary resuscitation (CPR).
In this randomized double-blinded controlled trial a total of 90 children(45 in each group) aged one to 13 years who required CPR during PICU stay were enrolled. Patients in whom vascular access was not available or return of spontaneous circulation (ROSC) was achieved by defibrillation without epinephrine were excluded. Also children with cardiac arrest outside PICU were not enrolled. All patients received CPR in accordance with the PALS-2015 guidelines established by the American Heart Association (AHA). The proportion of patients who achieved return of spontaneous circulation(ROSC) was the primary outcome measure and the survival rate,functional status post-resuscitation, need for organ transport were secondary outcome measures.
Key findings of the study are:
-The most common (80%) arrest rhythm was pulseless electrical activity (PEA). Hemodynamic abnormality (67.8%) was the most common event that led to arrest, followed by respiratory events (23.3%).
-The median (IQR) duration of CPR was similar between groups [18 (10-30) vs 15 (6–30) minutes; P=0.96].
-The proportion of patients who achieved ROSC, time to achieve ROSC and the proportion of patients requiring ongoing CPR was similar between two groups during the first 30 minutes of CPR.
-Researchers found that the number of patients who required CPR beyond 30 minutes was also similar between two groups and none achieved ROSC.
-Mean (SD) diastolic blood pressure (DBP) was similar in epinephrine plus vasopressin group as compared to epinephrine plus placebo group during CPR.
The outcome of a pediatric cardiac arrest depends upon many factors, including the initial presenting rhythm, the place of cardiac arrest, early recognition of the arrest, and the underlying conditions.
At present, only a limited number of vasopressors are available for use in pediatric CPR, and insufficient data supporting their use [2]. The pediatric guidelines were extrapolated from adult clinical trials and animal studies.
The AHA recommends considering E-CPR during in-hospital pediatric cardiac arrest, when standard resuscitation has failed, especially in a potentially reversible cause of cardiac arrest.
Authors conclude-" The study concludes that a combination of epinephrine and vasopressin did not improve the rate of return of spontaneous circulation, survival, and favorable neurological outcomes in pediatric intensive care unit cardiac arrest resuscitation as compared to epinephrine and placebo".
Source: Sheriff A, Rameshkumar R, Chidambaram M, Maulik K, Kumar RS, Jamal A, Bhowmick R, Biswal N, Mahadevan S. Epinephrine Plus Vasopressin vs Epinephrine Plus Placebo in Pediatric Intensive Care Unit Cardiopulmonary Resuscitation: A Randomized Double Blind Controlled Clinical Trial. Indian Pediatr. 2021 Jul 15;58(7):624-630.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.